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Background: Hazelnut is reported as a causative agent of allergic reactions. However it is also an edible nut with
health benefits. The allergenic characteristics of hazelnut-samples after autoclaving (AC) and high-pressure (HHP)
processing have been studied and are also presented here. Previous studies demonstrated that AC treatments were
responsible for structural transformation of protein structure motifs. Thus, structural analyses of allergen proteins
from hazelnut were carried out to observe what is occurring in relation to the specific-IgE recognition of the related
allergenic proteins. The aims of this work are to evaluate the effect of AC and HHP processing on hazelnut in vitro
allergenicity using human-sera and to analyse the complexity of hazelnut allergen-protein structures.
Methods: Hazelnut-samples were subjected to AC and HHP processing. The specific IgE- reactivity was studied in 15
allergic clinic-patients via western blotting analyses. A series of homology-based-bioinformatics 3D-models (Cora 1,
Cora 8, Cora 9 and Cora 11) were generated for the antigens included in the study to analyse the co mplexity of their
protein structure. This study is supported by the Declaration of Helsinki and subsequent ethical guidelines.
Results: A severe reduction in vitro in allergenicity to hazelnut after AC processing was observed in the allergic clinic-
patients studied. The specific-IgE binding of some of the described immunoreactive hazelnut protein-bands: Cora 1
~18KDa, Cora 8 ~9KDa, Cora 9 ~35-40KDa and Cora 11 ~47-48 KDa decreases. Furthermore a relevant glycosylation
was assigned and visualized via structural analysis of proteins (3D-modelling) for the first time in the protein-allergen
Cora 11 showing a new role which could open a new door for allergenicity-unravellings.
Conclusion: Hazelnut allergenicity-studies in vivo via Prick-Prick and other means using AC processing are crucial to
verify the data we observed via in vitro analyses. Glycosylation studies provided us with clues to elucidate, in the near
future, mechanisms of the structures that contribute to hazelnut allergenicity, which thus, in turn, help alleviate food
allergens.
Keywords: Structural analysis of allergen-proteins and GlycosylationIntroduction
Food allergies are receiving more attention and seem to
be increasing, especially in Western countries [1-5].
Consumers are becoming more aware and are more
informed about food sensitivities, including allergies. Al-
lergies to hazelnuts, tend to be of a more severe nature,
causing life-threatening and sometimes fatal reactions.
Indeed, symptoms upon hazelnut- ingestion are often
confined to the mouth and throat, but severe systemic* Correspondence: elena.lopez.villar@gmail.com
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reproduction in any medium, provided the orreactions have been described in some patients [6-14].
Also, hazelnut is a good habit in a healthy nutritional
regimen. Type I food allergy is defined as an IgE-
mediated response to a protein (or proteins) in a food
source. It is not known why a food protein that is in-
nocuous and well-tolerated by most individuals, triggers
an allergic response in sensitive individuals [15-17].
The portion of the food protein recognized by IgE is
called the epitope. Epitopes are generally categorized as
linear or conformational, where linear epitope involves a
contiguous stretch of amino acids, and a conformational
epitope involves non contiguous amino acids which
form a three-dimensional/structural motif. Individualtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ward an allergen; however, the basis of such differential
sensitivities remains to be elucidated [17,18].
Moreover, studies of protein thermal conformational
stability under different treatments from both biochem-
ical and techno functional points of view need to be
extended [19,20]. In addition, it has been suggested that
modifications in allergenicity caused by thermal treat-
ments could provide a better understanding of the risk
of introducing hazelnuts into human daily food intake.
Furthermore Hansen et al., [21] indicated that roasting
of hazelnuts reduces the allergenicity. Also, Ortolani
et al., [22] selected subjects with a history of allergic reac-
tions on ingestion of hazelnut and determined how many
had true allergy by means of the double-blind, placebo-
controlled food challenge (DBPCFC), showing that 78% of
the analyzed subjects had a positive DBPCFC result.
In fact, allergy to hazelnuts has been frequently reported,
but data on the identification and characterization of the
hazelnut allergens, as well as on the reliability of the meth-
ods for in vitro and in vivo detection of specific IgE for
these allergens, are scarce. In addition, different researches
have indicated that post-translational modifications
(PTMs) like phosphorylation and glycosylation can play a
relevant role in allergenicity related to edible nuts includ-
ing hazelnuts [23]. On the other hand, sequence and struc-
tural information improve the prediction of allergenic
peptides. Motifs can also be mapped onto the 3D-
structure of a protein to identify epitopes and conserved
functional areas [24]. Combining sequence analysis with
structural representations can answer many questions
about the nature of the IgE epitopes of allergens [25].
While single amino acid differences may be quite
important in individual reactivity, a 3D view of the
identified IgE binding sites can provide missing in-
formation about the possible relationships between
structure and sequence [26].
We selected the hazelnut as an edible nut for its health
benefits which makes the hazelnut food processing in-
dustry one of significant economic impact and profit
[27-29]. The present study was specifically designed to
evaluate the effects of AC and HHP processing on the
allergenic characteristics of proteins from hazelnuts.
This study aimed to combine functional research
protein-allergen analysis via western blotting and struc-
tural analysis of allergen proteins from the hazelnut, in
order to observe what is occurring in relation to the spe-
cific recognition of the allergenic proteins from hazel-
nuts by IgE using sera from patients allergic to hazelnuts
with clinical significance. In addition, and in order to
analyze the complexity level of the structural arrange-
ments of the studied allergens, a bioinformatics study
was done, generating 3D structural models for all of
them looking for putative glycosylation motifs. As ageneral result, in all cases the structural complexity of
the modelled proteins could act as a molecular explan-
ation for the effects observed after AC treatment. As
was previously demonstrated [30], AC treatment signifi-
cantly modifies the proportion of secondary structural
elements in proteins, being thus putatively responsible
for their changes in allergenicity.Materials and methods
Statement of ethical approval
This study was conducted in compliance with the inter-
national “Declaration of Helsinki.” An informed consent
about the procedures as well as permission from the Ethical
Committee of 12 de Octubre and Carlos III Hospitals of
Health was obtained (http://www.madrid.org/cs/Satelite?
pagename=Hospital12Octure/Page/H12O_ home, http://
www.madrid.org/cs/Satellite?pagename=HospialCarlosIII).
This study adhered to the tenets of the Declaration of Hel-
sinki. (http://www.wma.net/e/policy/b3.htm). (Declaration of
Helsinki (1964), Belmont (1978) and agreement of Oviedo
(1997) - the basic principles for human and biological sam-
ples research studies -) (http://www.isciii.es/htdocs/index.
jsp). (“Working link”: http://www.madrid.org/cs/Satelite?
pagename=Hospital12Octure/Page/H12O_home).Plant material, AC and HHP processing
Raw and processed seeds were milled to pass through a
1 mm sieve (Tecator, Cyclotec 1093, Hoganas, Sweden),
and the resulting meal was defatted with n-hexane
(34 mL/g of flour) for 4 h, shaken, and air-dried after fil-
tration of the n-hexane. Defatted flour was extracted
twice in a solution of Sodium borate, pH 8.0, plus 0.5 M
NaCl at a 1:10 w/v ratio for 1 h at 4°C by stirring. The
extract was clarified by centrifugation at 27000 g for
20 min at 4°C, and the supernatants were dialyzed
against H2O for 48 h at 4°C using a dialysis membrane
with a cut-off of 3.5 kDa and freeze-dried. The protein
content of each sample was measured according to the
Leco dye-binding assay (Bio-Rad, Hercules, CA) using
bovine serum albumin (BSA; Sigma, St. Louis, MO) as a
standard. Defatted hazelnut flour samples (30 g) were
hydrolyzed (water 1:4 w/v, for 20 h, at 4°C). The
obtained solutions were subjected to centrifugation
(1200 rpm, 10 min.) and different processing of AC and
HHP were applied. The resulting pellets and superna-
tants were frozen and stored at -20°C. The AC and HHP
processing applied were: 121°C 15 min., 121°C 30 min.,
138°C 15 min., 138°C 30 min. and 300Mba, 400Mba,
500Mba and 600Mba, respectively. All the processed
hazelnut flour samples were centrifuged and frozen in
order to obtain the lyophilized ones to be analyzed.
(Note: Mba: units Milibar pressure, AC: Autoclave heat
process, HHP: high pressure process).
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Denaturing protein and SDS-PAGE gel were performed
essentially according to the method of Fling and Greger-
son [31]. Samples (10 g per well) were mixed 5:1 with
loading buffer (8% SDS, 8 mM EDTA, 40% glycerol, 1 M
-mercaptoethanol (-ME), and 0.01% bromophenol blue
in 0.25 M Tris–HCl, pH 7.5) heated at 100°C for
10 min, electrophoresis in 4–20% gradient analytical
SDS-polyacrylamide gels employing a Mini-Protean III
apparatus (Bio- Rad), and either stained with Coomassie
Brilliant Blue R-250 or transferred to poly (vinylidene
difluoride) (PVDF) membranes (Bio -Rad). For immuno-
blot, proteins (25 μg) were electrophoretically trans-
ferred from the gels to PVDF by applying a constant
current of 250 mA during 1.30 h at room temperature,
essentially according to the method of Towbin et al.
[32]. The membranes were stained with red-ponceau to
verify protein transfer. Western immunoblotting using
pooled human sera was done, as described later, with the
necessary modifications to optimize the hazelnut sample
analysis for this study [33]. Blots were blocked in
phosphate-buffered saline plus 0.1% Tween 20 contain-
ing 1% fat-free milk powder for 2 h at room temperature
and then incubated overnight at room temperature with
individual and pooled sera (1:5 dilution). For individual
serum and also for the pool of sera, a mouse anti-human
IgE mAb HE-2 ascitic fluid was used as first antibody
(diluted 1:4000 in blocking buffer) for 1 h at room
temperature (RT). After 4 washing steps (10 mins each
one with phosphate-buffered saline plus 0.1% Tween
20), a goat anti-mouse IgG peroxidise- conjugated anti-
body was used as second antibody (diluted 1:5000 in
½ v/v in blocking solution) for 1 h at RT. Finally, immu-
noreactive bands were visualized using the ECL chemilu-
miniscent kit (Bio-Rad). Coomassie-stained gels and
immunostained membranes were scanned using a HPS
scanjet 5590P densitometer. The files generated were
analyzed with Quantity One software (Bio-Rad) using
the precision plus protein standard TM (Biorad) pre-
stained SDS-PAGE protein mixture (Bio-Rad) as
standard.
Immuno-CAP-FEIA allergy blood test
For the CAP (fluorenzymeimmunoassay CAP Pharmacia
Diagnostic, Uppsala, Sweden) tests, each serum was
incubated with the same volume of progressive dilutions
(0.001–1 mg/mL) of each inhibitor protein solution in
PBS buffer for 14 h at 4°C with agitation. After incuba-
tion, the samples were centrifuged, hazelnut commercial
Immuno-CAP was then added, and specific IgE levels
were assessed, according to the CAP System procedure
(Pharmacia Diagnostic, Uppsala, Sweden). BSA was used
as negative control. The assay was performed in duplicate
samples, and each one was tested in duplicate [34-36].Patients
Fifteen patients (from num.3 until num.17- Figure 1 A,
B, C) with detectable hazelnut- specific IgE as quantified
by the CAP-FEIA assay (> 0.35 kilounits/L) (Pharmacia
Diagnostic, Uppsala, Sweden) (Table 1), were use to
evaluate the reduction in allergenicity by thermal treat-
ment of hazelnut. The fifteen patients were selected as
they belong to hazelnut-allergic patients without allergy
to another edible nut.
In addition, patient num.1 and patient num.2 –Figure 1
A- were used as negative controls - with negative spe-
cific IgE recognition to hazelnuts and quantified by
using the (CAP-FEIA assay (< 0.35 kilounits/L, Pharma-
cia Diagnostic, Uppsala, Sweden). The negative controls
were selected as they belong to healthy patients without
allergy to edible nuts in order to focus the data in
allergen-hazelnut recognised protein-bands from human
IgE hazelnut- allergic patients.
Structural analysis and modelling procedures of hazelnut
proteins Cor_a_1.04, Cor_a_8, Cor_a_9 and Cor_a_11
3D models of hazelnut alergens Cor_a_1.04 (Uniprot
codes: Q9FPK2, Q9FPK3, Q9FPK4 and Q9SWR4),
Cor_a_8 (Uniprot code: Q9ATH2), Cor_a_9 (Uniprot
code: Q8W1C2) and Cor_a_11 (Uniprot code: Q8S4P9)
were generated using homology modelling procedures
and the coordinates of the following Protein Data Bank
structures as templates:
Cor_a_1.04. Template: Crystal structure of major
pollen allergen Bet v 1d/h from Betula pendula. Protein
Data Bank code: 3 K78 [37]. Blast E-value: 6.1x10− 55.
Sequence Identity: 66%
Cor_a_8. Template: Crystal structure of Pru p3, non-
specific lipid transfer protein from Prunus persica.
Protein Data Bank code: 2ALG_A [38]. Blast E-value:
1.3x10− 29. Sequence Identity: 59%
Cor_a_9. Template: Crystal structure of the hexameric
form of Pru du amandin from Prunus dulcis. Protein
Data Bank code: 3EHK [39]. Blast E-value: 1.4x10− 146.
Sequence Identity: 56%
Cor_a_11. Template: Crystal structure of soybean
beta-conglycinin beta homotrimer. Protein Data bank
code: 1IPK [40]. Blast E-value: 2.0x10 − 63. Sequence
Identity: 354%
Models were built using the SWISS-MODEL server
[41-43] available at http://swissmodel.expasy.org//SWISS-
MODEL.html, and their structural quality was checked
using the analysis programmes provided by the same ser-
ver (Anolea/Gromos). Global model quality estimation
scores QMEAN4 [44] were: Cor_a_1.04: 0.741, Cor_a_8:
0.671, Cor_a_9: 0.548 and Cor_a_11: 0.608, that are within
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Figure 1 Western blotting analysis of hazelnut processed by AC and HHP treatments. Western blotting analysis of AC/HHP flour hazelnut
samples incubated with clinical sera from patients allergic to hazelnut (*) Figure 2 is illustrated in 3 sections (A), (B) and (C) in order to visualize
34 western blots in a proper way. Number 1 corresponds to raw hazelnut flour; numbers 2, 3, 4 and 5 correspond to AC 121°C 15 mins., 121°C 30
mins., 138°C 15 mins., and 138°C 30 mins., respectively. Numbers 6, 7, 8 and 9 correspond to HHP 300Mba, 400Mba, 500Mba and 600Mba
respectively. Sera 1 and 2 correspond to non allergic patients to hazelnut (negative controls). (Note: (i) The film-exposition - after the ECL
incubation- took longer than 24 h to visualize the bands of the negative controls: sera 1 and 2) (ii) The film-exposition - after the ECL incubation-
took between 5 s and 1 min. according to the different sera tested in order to visualize the bands: from serum 3 until 17) (MW: molecular weight,
AC: autoclave process, HHP: high pressure process, KDa: kilodalton).
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Table 1 Illustration of clinic symptoms of patients allergic
to hazelnut
Patient Age Sex Reported symptoms CAP
# 1 57 F 0
# 2 33 F <0.35
# 3 26 M Oral allergy syndrome 2.68
# 4 33 F Acute urticaria 2.5
# 5 16 F Avoidance 2.97
# 6 28 F Oral allergy syndrome 4.03
# 7 16 F Oral allergy syndrome 2.08
# 8 21 M Systemic anaphylaxis 4.6




# 10 27 F Systemic anaphylaxis 1.92
# 11 30 M Oral allergy syndrome 2.42
# 12 42 F Oral allergy syndrome 1.9
# 13 28 M Avoidance 0.87
# 14 57 F Oral allergy syndrome 2.5
# 15 47 M Oral allergy syndrome 4.13
# 16 30 F Avoidance 0.42
# 17 49 M Avoidance 0.47
Patients allergic to hazelnut proteins showed clinic symptoms from oral allergy
syndrome, acute urticaria, systemic anaphylaxis, rhinoconjunctivitis,
angioedema to avoidance (avoidance: advised to avoid hazelnut food because
of a positive skin test). The resulting data including the age and sex, are
illustrated in this table. (Note: F: female, M: male).
Avoidance*: advised to avoid the food because of a positive skin test, without
a clinical history of hazelnut allergy.
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minimized using the GROMOS 43B1 force field imple-
mented in DeepView [45,46], using 500 steps of steepest
descent minimization followed by 500 steps of conjugate-
gradient minimization.
Figures were generated using the Pymol Molecular
Graphics System (Schrödinger, LLC). [SWISSPROT
database http://expasy.org/sprot/].
Results
SDS-PAGE gel and immunoblotting analyses
(a)The allergenicity was analyzed by IgE-
immunoblotting. In the case of the raw- hazelnut
flour (positive control), IgE antibodies from 15
individual sera allergic to hazelnut recognized bands
at (a) ~ 9 KDa bands which correlate with Cor_a_8
protein –non-specific lipid transfer proteins family
(nsLTPs), (b) ~ 18 KDa bands which belongs to
Cor_a_1.04 protein –Bet v1 family-, (c) ~35–40 KDa
bands which belong to Cor_a_9 protein – 11 S seed
storage globulin, cupin family- and (d) ~47–48 KDa
bands which belong to Cor_a_11 protein –Vicilinfamily-. A severe reduction in allergenicity to
hazelnut flour in vitro after autoclaving at 121°C 15
mins., 121°C 30 mins., 138°C 15 mins and 138°C 30
mins, was observed in the allergic clinic patients
with a CAP value> 0.35 kilounits/L by western
blotting analysis. No reduction in allergenicity
in vitro after HHP treatments was observed in any
serum of the 15 patients, which were also analyzed
by immunoblotting when using the same conditions
for all the sera analyses [31-33].
(b)Autoclaving 121°C 15 mins and 121°C 30 mins
hazelnut flour samples, which were analyzed by
western blotting showed that, mainly the IgE
binding of some of the described immunoreactive
hazelnut protein-bands (Cor_a_1 ~18KDa, Cor_a_8
~9KDa-, Cor_a_9 ~35–40KDa) decreases. This
occurred in the majority of sera tested. Autoclaving
treatments 138°C 15 mins and 138°C 30 mins of
hazelnut flour samples, which were analyzed by
western blotting, showed that the IgE binding of all
of the described immunoreactive hazelnut protein-
bands (Cor_a_1 ~18 KDa, Cor_a_8 ~ 9 KDa-,
Cor_a_9 ~35-40 KDa, Cor_a _11 ~47–48 KDa)
disappear. This occurred in all the sera tested (15
western blotting analyses from 15 clinical sera of 15
patients diagnosed with actual allergy to hazelnuts).
[Molecular weights (MW) and allergen names are
described in Database Food Allergies and Swissprot
Database - ExPaSy Proteomic Server respectively;
http://foodallergens.ifr.ac.uk/default.html, http://
www.uniprot.org/uniprot/, http://expasy.org/sprot/].
(c)All protein bands from Coomassie-stained gel and
immunostained membranes were scanned using a
HPS scanjet 5590P densitometer. The files generated
were analyzed with Quantity One software (Bio-
Rad), which allowed us to visualize the severe
reduction in allergenicity in vitro via the decrease of
intensity of the protein-bands when comparing the
raw-hazelnut flour (positive control: 100% intensity)
with the autoclaved samples: 121°C 15 mins., 121°C
30 mins., 138°C 15 mins and 138°C 30 mins. Indeed,
severe allergenicity reduction in vitro was ensured
via p ≤ 0.05 value obtained via Quantity One
software and excel for all studied patients.
(d)When loading ~25 μg of soluble proteins in loading
buffer, the raw hazelnut flour does not show a
different protein pattern compared to the processed
ones by HHP treatments (from Sera 3 to 17) (down-
panel HHP Figure 1 A, B, C). Nevertheless, the raw
hazelnut flour shows a different protein pattern
compared to that processed by AC treatments.
Strongest conditions of the AC treatment decrease
the IgE binding of allergenic hazelnut proteins (from
Sera 3 to 17). In the case of the analysis of the
Figure 2 (See legend on next page.)
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Figure 2 3D structure models for Cor_a_1.04 proteins. (A). 3D models for the four Cor_a_1.04 proteins (Uniprot codes: Q9FPK2, Q9FPK3,
Q9FPK4 and Q9SWR4). Models are coloured from N-ter (blue) to C-ter (red) ends. (B). Structure alignment of the four Cor_a_1.04 proteins
identified by their Uniprot codes, and the crystal structure of major pollen allergen Bet v 1d/h from Betula pendula (PDB code: 3 K78; [35]).
Secondary structure elements of both the model and template are included. Differences among the sequences of the four Cor_a_1.04 proteins
are indicated in red.
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KDa is observed in the lanes of the raw flour, 121°C
15 mins., and 121°C 30 mins. Nevertheless, this
protein-band (> 15KDa) disappears in the lanes of
the 138°C 15 mins., and 138°C 30 mins. In the case
of the analysis of the Serum 2 (CAP< 0,35): (i) The
raw hazelnut flour does not show a different protein
pattern compared to that processed by HHP
treatments (down- panel HHP Figure 1). (ii) The
raw hazelnut flour shows a different protein pattern
compared to that processed by AC treatments.
Strongest conditions of the AC treatment decrease
the IgE binding of allergenic hazelnut proteins. (up-
panel AC Figure 1 A, B, C).
(e) In addition, other negative control (as internal
control, intra-assay) which was also used, is the
incubation of raw hazelnut flour with the first and
secondary antibodies (a mouse anti-human IgE mAb
HE-2 ascitic fluid and a goat anti-mouse IgG
peroxidise- conjugated antibody) respectively. In the
lane of the negative control protein-bands were not
visualized as a good evaluation.
CAP-FEIA of patients allergic to hazelnuts
Patients allergic to hazelnut proteins were selected for
this research study.
Fifteen patients showed clinic symptoms including oral
allergy syndrome, acute urticaria, systemic anaphylaxis,
rhinoconjunctivitis, angioedema and avoidance (avoid-
ance: advised to avoid hazelnut food because of a posi-
tive skin test).
The resulting data including the age and sex, are illu-
strated in the Table 1.
Structural analysis Modelling procedures of hazelnut
proteins Cor_a_1.04, Cor_a_8, Cor_a_9 and Cor_a_11
3D structural models were generated for the allergenic
hazelnut antigens of this study:
Cor_a_1.04, Cor_a_8, Cor_a_9 and Cor_a_11 proteins. In
the four cases, the structure of close homologue proteins
were already available in the Protein Data Bank as
crystallized structures, allowing the generation of good
quality models. Cor_a_1.04 antigen is represented by four
individual, closely related, proteins (Uniprot database
codes: Q9FPK2, Q9FPK3, Q9FPK4 and Q9SWR4).
Models for the four Cor_a_1.04 proteins wereconstructed using as template the crystal structure of the
close relative major pollen allergen Bet v 1d/h from
Betula pendula (PDB code: 3 K78; [37]). Due to the very
similar sequence of the four proteins (Figure 2B), the
generated 3D models were nearly identical (Figure 2A),
exhibiting a complex alpha+beta scaffolding.
Model for the soluble domain of Cor_a_8 protein, after
signal peptide processing, was built according to the 3D
structure of the crystal structure of Pru p3, non-specific
lipid transfer protein from Prunus persica (PDB code:
2ALG_A; [38]). Figure 3A shows the structure of the
obtained model, enriched in alpha helix elements located
in close contact to two lipid molecules, as predicted
according to its sequence similarity to the template
(Figure 3B).
In the case of Cor_a_9 allergen, a extremely complex,
beta sheet-enriched, structure is predicted composed of six
monomers arranged in two trimeric structures positioned
in a base-to-base dimeric assembly (Figure 4A-B), as
deduced by the close sequence similarity to the crystal
structure of Pru du amandin from Prunus dulcis (PDB
code: 3EHK; [39]), as shown in Figure 4C. Some protein
segments, probably forming mobile non-structured loops,
were not included in the model (Figure 4C, residues
coloured in red) due to the lack of an adequate structural
template, as their counterparts are also missing in the ori-
ginal crystal structure.
Similarly to Cor_a_9, Cor_a_11 antigen was also
modelled as a trimeric structure, formed by three beta
sheet-enriched monomers (Figure 5A-B). Modelled spatial
arrangement is equivalent to that exhibited by the selected
template, the crystal structure of soybean beta- conglycinin
beta protein (PDB code: 1IPK; [40]) based on their se-
quence similarity (Figure 5D). It has been reported that
Cor_a_11 was glycosylated in residue Asn301 via MALDI–
TOF (matrix-assisted laser-desorption ionization–time-of-
flight) MS mode analyses [41]. Position of a molecule of N-
acetyl-D-glucosamine (NAG) was also modelled bound to
Asn301, a residue located in a very structured, beta sheet-
enriched domain. As shown -for the first time- in
Figure 5C, glycosylated residue is positioned on the surface
of the protein, additionally validating the model.
The obtained structural models of the four studied
allergenic proteins indicated in all cases that a highly
complex arrangement is present in all cases, includ-
ing both alpha and beta secondary elements as well
Figure 3 3D structure model for Cor_a_8 protein. (A). 3D model for Cor_a_8 protein. A. Front (left) and reverse (right) faces are shown.
Position of putative lipid molecules, present in the template structure, is indicated. (B). Structure alignment of Cor_a_8 protein and the crystal
structure of Pru p3, non-specific lipid transfer protein from Prunus persica (PDB code: 2ALG_A; [36]). Secondary elements are indicated as in
Figure 1. Position of signal peptide is also highlighted.
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Recently, it has been concluded, using Synchrotron-
based Fourier transform infrared microspectroscopy
[30], that AC treatments substantially modified the
protein structure alpha-helix to beta-sheet ratio.
Taking into account the structured scaffolds of
Cor_a_1.04, Cor_a_8, Cor_a_9 and Cor_a_11 pro-
teins, as deduced from bioinformatics modelling,
disorganization of such structures would lead to large
modifications in the arrangement of their respective
structure-dependant allergenic motifs.
Discussion
The hazelnut was selected in this research study for two
reasons: (1) it is well recognized that allergies to hazel-
nuts are tending to be of a more severe nature, causinglife-threatening and unfortunately sometimes fatal reac-
tions, and (2) it is also an edible nut with health benefits,
as it is one of the best known sources for vitamin E, and
a good source also for B1, B2 and B6 vitamins. Indeed,
the hazelnut has several important health benefits in
protection against diseases. Moreover, for example, vita-
min E -found in a high level/amount in hazelnuts- pre-
vents the factors which prepare the basis for cancer
disease. The reason is because if cancer is already
formed in the body, then the vitamin E contained in
hazelnuts fights to defuse the harmful cells [6-14]. In
addition, the patients were selected as they clearly
showed clinic hazelnut allergy data (Table 1).
Our results show for the first time that HHP proces-
sing (300Mba, 400Mba, 500Mba and 600Mba) of hazel-
nut flour samples analyzed via western blotting analyses
Figure 4 3D structure model for Cor_a_9 homohexameric
protein. (A). 3D model for Cor_a_9 hexamer (left) and single chain
(right), top view. (B). Same as A, side view. (C). Structure alignment
of Cor_a_9 protein sequence and the crystal structure of Pru du
amandin from Prunus dulcis (PDB code: 3EHK; [37]). Secondary
elements are indicated as in Figure 1. Position of signal peptide is
highlighted. Non-structured segments, absent in the template
structure and therefore not modelled for Cor_a_9 sequence, are
coloured in red.
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Cor_a_1, Cor_a_8, Cor_a_9 and Cor_a _11 protein-
allergens in the 15 studied patients (Figure 1 A, B, C).
Also, the HHP hazelnut processed samples show a simi-
lar protein-pattern compared to the same samples with-
out any HHP processing (raw hazelnut) via SDS-PAGE
gel (Figure 6B).
A relevant point to make, is that when observing the
western-blotting analyses of serum 2 (CAP< 0,35 kilou-
nits/L) –this serum corresponds to a patient without al-
lergy to hazelnut- protein-bands of a molecular weight
(MW) ~37 and ~15 Kda are observed (Figure 1 A,
Serum 2). We assume this is –maybe- because of cross-
reactivity among different edible nuts. It has been
described that people with hazelnut allergies can also
often suffer from reactions triggered by a number of dif-
ferent types of nuts, even though they do not come from
closely related plant species [15-18].
At this level, one can ask: Why do some individuals
show cross-reactivity to homologous proteins in tree
nuts? One explanation could be that while single amino
acid differences are very important in individual reactiv-
ity, the visualizations of the identified IgE binding sites
via 3D, can achieve relevant biological understanding
about the possible relationship among structures and
sequences. Moreover, if IgE binding sequences of related
proteins have similar properties, the underlying assump-
tion is that for a group of cross-reactivity allergenic pro-
teins, the IgE epitopes areas have similar binding
affinities for the same antibodies, and have, thus, com-
mon physic chemical properties in the antibody binding
sites [25-29]. Furthermore, PTM analyses (e.g. glycosyla-
tion) allow a comprehensive investigation of complete
allergens. It provides clues to elucidate mechanisms of
the structures that contribute to allergenicity, which
thus, in turn, help alleviate food allergens [47-50], and
so improve the knowledge of immunologic disorders as
allergenicity processes (see Figures 2, 3, 4 and 5).
AC processing (121°C 15 mins., 121°C 30 mins., 138°C
15 mins., and 138°C 30 mins.,) of hazelnut-flour samples
analyzed via western blotting manifest that, the IgE binding
of Cor_a_1, Cor_a_8, Cor_a_9 and Cor_a _11 protein-
allergens decreases in the 15 allergic studied patients.
Figure 5 3D structure model for Cor_a_11 homotrimeric protein. (A). 3D model for Cor_a_11 trimer. Front (left) and side (right) faces are
shown. Position of putative glycosylated Asn301 is indicated. (B). Cor_a_11 protein, single chain. (C). Putative position of glycosylated Asn301 in
the surface of the protein. (D). Structure alignment of Cor_a_11 sequence and the crystal structure of soybean beta-conglycinin beta protein
(PDB code: 1IPK; [38]). Positions of signal peptide and the putative glycosylated Asn301 residue are highlighted.
López et al. Journal of Clinical Bioinformatics 2012, 2:12 Page 10 of 13
http://www.jclinbioinformatics.com/content/2/1/12Indeed, immunoreactive hazelnut protein-bands disappear
(Figure 1 A, B, and C, serum num. 3 until serum num.
17). In addition, via SDS-PAGE analysis, we could observe
that the protein-patterns from the AC hazelnut-processed
samples were different compared to the protein-pattern of
the raw-hazelnut (without AC treatment) (Figure 6 A). It
would seem relevant to ask at this point: are protein-
allergens from hazelnut-processed samples via AC proces-
sing aggregated? Without much doubt, yes, and probably
PTMs (e.g. glycosylation) are altering the molecular struc-
ture of some hazelnut allergen-proteins when they are
autoclaved [15-20,42-51]. Thus, AC processing of hazel-
nut seems to be affecting the 3D-structure of its allergen-
proteins. Perhaps due to the AC-processing, it might pos-
sible that Ag-Ab-interactions are modified, as hazelnut
IgE mediated allergy is triggered by the proteins which re-
sist processes such as cooking –for example [52-59].
In the four modelled antigen proteins, with the excep-
tion of the all-alpha Cor_a_8 protein, 3D structure canbe classified as a mixed alpha + beta scaffolding, includ-
ing also a variable percentage of non-structured loops
connecting the secondary structure elements. From the
point of view of antigenic properties, epitopes can be
divided in linear and structural ones, corresponding
mainly to sequence regions folded into well defined 3D
structure (alpha and beta chains) or into mainly unstruc-
tured loops. As has been demonstrated previously [30],
AC treatments modified the alpha to beta ratio, thus
affecting mainly the 3D epitopes, and to a lesser extent
to linear epitopes potentially located among them.
Structure models for Cor_a_1.04 proteins (Figure 2)
showed that most of the protein sequence is struct
ured, the loops being located almost exclusively as
the apical structures of beta-turns, and so very influ-
enced by the beta structure itself. In this case, AC
treatments are expected to be very effective, as
mainly all epitopes are predicted to be structure-
dependant.
Figure 6 Hazelnut flour samples analyzed by SDS-PAGE
4–20%: the wild-raw proteins and the raw-processed proteins
by autoclaving and high pressure with different treatments are
illustrated. (A) The electrophoresis analysis of hazelnut flour
samples shows that the different protein- patterns can be observed
once the raw flour (lane 1) is processed by autoclaving (AC)
treatments (lanes 2, 3, 4 and 5). Lane 2 corresponds to AC 121°C 15
mins. Lane 3 corresponds to AC 121°C 30 mins. Lane 4 corresponds
to AC 138°C 15 mins. Lane 5 corresponds to AC 138°C 30 mins.
~25 μg of soluble proteins in loading buffer (containing 1 M -
mercaptoethanol) was inserted into each lane. (B) By electrophoretic
analysis of hazelnut flour samples, it is observed that the protein-
patterns of the raw (lane 1) show similar patterns when processed
by high pressure (HHP) treatments (lanes 6, 7, 8 and 9). Lane 6
corresponds to HHP 300Mba. Lane 7 corresponds to HHP 400Mba.
Lane 8 corresponds to HHP 500Mba. Lane 9 corresponds to HHP
600Mba. ~25 μg of soluble proteins in loading buffer (containing
1 M -mercaptoethanol) was inserted into each lane. (MW: molecular
weight, AC: autoclave process, HHP: high pressure process, KDa:
kilodalton).
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(Figure 3) exhibited a very similar arrangement, the
small-size loops being located exclusively as linkers be-
tween alpha helices. Equally as for Cor_a_1.04 proteins,
AC treatment for Cor_a_8 is predicted to disorganize al-
most all possible epitopes. The large and complex model
for Cor_a_9 antigen (Figure 4), is, in contrast, predicted
to be composed not only of a very structured, beta-sheet
enriched, protein core, but also of long unstructured
loops. These loops (red sequences in Figure 4C) cannot
be modelled due precisely to their lack of stablestructure, but they are predicted to carry linear epitopes,
as they are located in the external faces of the protein
hexamer and thus exposed to the solvent.
Nevertheless, no band of a compatible size was
detected after lengthy AC treatments (Figures 1 and
6), probably indicating that the predominant antigeni-
city was due to structural and not linear epitopes. Fi-
nally, model for Cor_a_11 protein (Figure 5)
indicated that this protein contains a low proportion
of unstructured loops, being enriched in beta-sheet
structures. According to this fact, AC treatment
resulted in the lack of antigenicity. The model of
Cor_a_11 also predicted a suitable structure arrange-
ment for a NAG group attached to Asn 301 residue,
as the initial site for glycosylation of the protein. Pos-
ition of Asn 301 in a structured beta sheet makes
this position a candidate for structural changes after
AC treatment and thus to a putative loss of antigeni-
city due to the presence of sugar moiety. In addition,
in vivo assays with the AC-processed hazelnut sam-
ples (for example via Prick- Prick) will be performed
in the future, in order to verify if specific immunor-
eactions, mediated by IgE, decrease in those patients
diagnosed with allergy to hazelnuts [60,61].
Conclusions
An important reduction in allergenicity in vitro to hazel-
nut flour after AC processing was observed in the aller-
gic clinic patients studied via western blotting analyses,
while no reduction in allergenicity after HHP processing
was observed.
Allergenicity processes are in a great manner
dependent on the molecular recognition of specific
structure motifs of proteins and their variation could
be a putative explanation for the effects of AC pro-
cessing on the allergenicity of the immunoreactive
hazelnut protein-bands. Thus, a series of homology-
based bioinformatics 3D models were generated. The
visualization of a relevant glycosylation for the first
time in the protein-allergen Cor-a-11 structure was
observed, showing a new role which could open a
new door for allergenicity- unravellings according to
the data presented in this article.
A high number of technique-combination-
approaches are available for clinical allergy research.
It is always necessary to test different strategies in
order to reach a greater level of efficiency for your
clinical study according to the type of samples to be
analyzed. We aimed to detail the current and useful
techniques to carry out in vitro allergenic studies
which may be helpful for understanding hazelnut al-
lergy, IgE mediated. This study is also aimed at com-
bining functional research protein-allergen analysis
with structural analysis of allergenic proteins, in
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which can help to unravel biological understanding
with clinical significance. Nowadays it is essential that
clinicians and scientific experts work together in
order to improve the therapies and diagnosis
advances for hazelnut allergy disease.
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